ClinicalTrials.gg
RecruitingNCT07550647Updated Apr 24, 2026

Early Rehabilitation After Total Hip Arthroplasty

An interventional study of Early Postoperative Physiotherapy and Neuromuscular Electrical Stimulation (NMES) in Total Hip Arthroplasty (THA), sponsored by Muğla Sıtkı Koçman University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 50 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-04-24.

Sponsored by Muğla Sıtkı Koçman University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
52
Allocation
Randomized
Ages
50 Years to 75 Years
Sex
All
01

Study summary

This study aims to investigate the effects of an early postoperative rehabilitation program combined with neuromuscular electrical stimulation (NMES) and telerehabilitation on functional recovery in patients undergoing total hip arthroplasty (THA).

In the early postoperative period, patients commonly experience muscle weakness, impaired gait, and functional limitations that may delay recovery. Early rehabilitation has been shown to improve functional outcomes, while NMES may enhance muscle activation, particularly in hip abductor muscles. Additionally, telerehabilitation may support continuity of care following discharge by enabling supervised home-based exercise.

In this prospective study, participants will be assigned to either an intervention group receiving early physiotherapy combined with NMES and telerehabilitation, or a control group receiving standard postoperative care. Functional outcomes, gait parameters, quality of life, and muscle-related changes will be evaluated at predefined time points.

Read the detailed description

This study is designed as a prospective, randomized controlled clinical trial to evaluate the effectiveness of an early postoperative rehabilitation program combined with neuromuscular electrical stimulation (NMES) and telerehabilitation in patients undergoing total hip arthroplasty (THA).

Following THA, patients frequently experience muscle weakness, gait asymmetries, and reduced functional capacity, which may prolong recovery. Although early mobilization and rehabilitation are widely recommended, the combined effects of NMES and telerehabilitation within a structured early-phase rehabilitation program have not been sufficiently investigated.

Participants will be randomly allocated into intervention and control groups using a simple randomization method. The intervention group will receive a structured physiotherapy program initiated on the first postoperative day and continued daily during hospitalization. This program will be combined with NMES targeting the gluteus medius muscle, applied using surface electrodes placed over the motor point with stimulation parameters adjusted according to patient tolerance.

After discharge, participants in the intervention group will continue a structured home-based exercise program supported by synchronous telerehabilitation sessions conducted three times per week. These sessions will enable real-time supervision, feedback on exercise performance, and progression based on standardized tolerance criteria.

The control group will receive the standard postoperative care protocol routinely applied in the clinic, without additional NMES or telerehabilitation support.

All participants will be evaluated at predefined time points: preoperatively (within 3 days before surgery), at discharge (postoperative day 6), and at postoperative week 4. Outcome assessments will be performed by an experienced physiotherapist blinded to group allocation, and intervention delivery and outcome assessment will be conducted by different physiotherapists.

The primary objective of the study is to determine whether the addition of NMES and telerehabilitation to early rehabilitation improves functional recovery following THA. Secondary objectives include evaluating changes in muscle strength, joint mobility, pain levels, gait characteristics, and muscle morphology.

02

Conditions studied

  • Total Hip Arthroplasty (THA)

Keywords

  • Rehabilitation
  • Total Hip Arthtoplasty
03

In context

Lead sponsor

Muğla Sıtkı Koçman University is the lead sponsor of 115 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
50 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients scheduled for unilateral total hip arthroplasty due to osteoarthritis or developmental dysplasia of the hip (DDH)
  • Aged between 50 and 75 years
  • Willing and able to participate in all follow-up assessments
  • Able to comply with assessment procedures
  • Able to meet the requirements of telerehabilitation
  • Undergoing surgery with a standardized surgical protocol

Exclusion criteria

Exclusion Criteria:

  • Previous history of total hip arthroplasty on either side
  • Planned revision total hip arthroplasty
  • Severe osteoarthritis in the contralateral hip
  • Presence of severe acute metabolic, neuromuscular, or cardiovascular disease
  • History of active
  • Presence of respiratory infection
  • Concomitant orthopedic conditions (e.g., lower extremity fractures, severe hip/knee deformities, lumbar or sacroiliac dysfunction)
  • >35
  • Occurrence of postoperative complications (e.g., prosthetic infection, thromboembolic events, or conditions requiring reoperation)
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
52 participants (estimated)

Study arms

  • Experimental
    Experimental Group (Early Physiotherapy + NMES + Telerehabilitation)

    Participants will receive a structured physiotherapy program initiated on the first postoperative day, including exercise and neuromuscular electrical stimulation (NMES) targeting the gluteus medius during hospitalization (5 days). After discharge, the intervention will continue with a 3-week home-based exercise program supported by synchronous telerehabilitation sessions conducted three times per week.

    Other: Early Postoperative Physiotherapy · Device: Neuromuscular Electrical Stimulation (NMES) · Other: Telerehabilitation

  • Active comparator
    Control Group (Standard Care)

    Participants will receive the hospital's standard postoperative care during hospitalization, including routine monitoring and wound care without a structured physiotherapy program. At discharge, they will be provided with a home exercise brochure with instructions but will not receive supervised telerehabilitation.

    Other: Standard Postoperative Care

Interventions

  • OtherEarly Postoperative Physiotherapy

    A structured physiotherapy program including mobilization and therapeutic exercises initiated on postoperative day 1 and continued daily until discharge (5 days).

  • DeviceNeuromuscular Electrical Stimulation (NMES)

    NMES applied to the gluteus medius muscle starting on postoperative day 1, administered daily for 5 days using standard stimulation parameters to enhance muscle activation.

  • OtherTelerehabilitation

    A 3-week home-based exercise program supported by synchronous video-based telerehabilitation sessions conducted three times per week after discharge.

  • OtherStandard Postoperative Care

    Routine postoperative care including wound monitoring and general medical follow-up during hospitalization. At discharge, patients receive a home exercise brochure without supervised rehabilitation or telerehabilitation.

06

What researchers measure

Primary outcomes

  1. Timed Up and Go (TUG) Test

    Functional mobility will be assessed using the Timed Up and Go (TUG) test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4.

  2. 10-Meter Walk Test (10MWT)

    Gait speed will be assessed using the 10-Meter Walk Test. Walking speed will be recorded in meters per second (m/s).

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  3. Stair Climb Test

    Functional lower extremity performance will be assessed using the Stair Climb Test. The time required to ascend and descend a standardized flight of stairs will be recorded in seconds.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

Secondary outcomes

  1. 6-Minute Walk Test (6MWT)

    Functional exercise capacity will be assessed using the 6-Minute Walk Test. The total walking distance covered in 6 minutes will be recorded in meters.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  2. Hip Muscle Strength (Manual Muscle Testing)

    Hip muscle strength (flexion, extension, and abduction) will be evaluated using Manual Muscle Testing, graded on a scale from 0 to 5, where 0 indicates no muscle contraction and 5 indicates normal muscle strength. Higher scores indicate better muscle strength.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  3. Range of Motion (ROM)

    Hip joint range of motion (flexion, extension, and abduction) will be measured using a goniometer and recorded in degrees. Higher values indicate greater joint mobility.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  4. Pain Intensity (Visual Analog Scale - VAS)

    Pain intensity during movement will be assessed using the Visual Analog Scale (VAS), a 10-centimeter scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate worse pain.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  5. Hip Function and Quality of Life (International Hip Outcome Tool-12)

    Hip-related function and quality of life will be assessed using the International Hip Outcome Tool-12 (IHOT-12). Scores range from 0 to 100, with higher scores indicating better hip function and quality of life.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  6. Gluteus Medius Muscle Sarcopenia (CT-Based Assessment)

    Gluteus medius muscle sarcopenia will be assessed using computed tomography (CT) imaging. Muscle cross-sectional area and composition will be analyzed.

    Time frame: Preoperative (within 3 days before surgery) and postoperative week 4

  7. Step Length

    Step length will be assessed using gait analysis methods and recorded in meters. Higher values indicate better gait performance.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  8. Cadence

    Cadence will be assessed using gait analysis methods and recorded as steps per minute. Higher values indicate better gait performance.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

  9. Walking Speed

    Walking speed will be assessed using gait analysis methods and recorded in meters per second (m/s). Higher values indicate better gait performance.

    Time frame: Preoperative (within 3 days before surgery), postoperative day 6 (at discharge), and postoperative week 4

07

Study locations

1 of 1 sites recruiting
  • Niğde Ömer Halisdemir University, Education and Research Hospital
    Niğde, Merkez 51200, Turkey (Türkiye)
    Recruiting
08

References and documents

Publications

  • Baldwin ER, Klakowicz PM, Collins DF. Wide-pulse-width, high-frequency neuromuscular stimulation: implications for functional electrical stimulation. J Appl Physiol (1985). 2006 Jul;101(1):228-40. doi: 10.1152/japplphysiol.00871.2005. Epub 2006 Apr 20. PubMed 16627680 ↗
  • Marchisio AE, Ribeiro TA, Umpierres CSA, GalvAo L, Rosito R, Macedo CAS, Galia CR. Accelerated rehabilitation versus conventional rehabilitation in total hip arthroplasty (ARTHA): a randomized double blinded clinical trial. Rev Col Bras Cir. 2020;47:e20202548. doi: 10.1590/0100-6991e-20202548. Epub 2020 Aug 12. English, Portuguese. PubMed 32844909 ↗
  • Madara KC, Marmon A, Aljehani M, Hunter-Giordano A, Zeni J Jr, Raisis L. PROGRESSIVE REHABILITATION AFTER TOTAL HIP ARTHROPLASTY: A PILOT AND FEASIBILITY STUDY. Int J Sports Phys Ther. 2019 Jul;14(4):564-581. PubMed 31440408 ↗
  • Monaghan B, Grant T, Hing W, Cusack T. Functional exercise after total hip replacement (FEATHER): a randomised control trial. BMC Musculoskelet Disord. 2012 Nov 28;13:237. doi: 10.1186/1471-2474-13-237. PubMed 23190932 ↗

Individual participant data

Plan to share: Undecided — At this stage, the plan for sharing individual participant data has not yet been determined.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2026; primary completion for Jul 2027, 15 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2026
First posted
Apr 24, 2026
StartEst.
Apr 2026
Primary completionEst.
Jul 2027
CompletionEst.
Oct 2027
Last update
Apr 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07550647
Responsible party
Cansu DAL (Specialist Physiotherapist, Muğla Sıtkı Koçman University) — Principal investigator
First posted
Apr 24, 2026
Start date
Apr 2026 (estimated)
Primary completion
Jul 2027 (estimated)
Completion
Oct 2027 (estimated)
Last update
Apr 24, 2026

Study contacts

Cansu Dal, Specialist Physiotherapist
Contact
ptcansudal@gmail.com
+905379773071

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion